Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug could protect divers from the bends

NCT ID NCT06216366

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 26 times

Summary

This study tests whether an experimental drug called rhu-pGSN can reduce harmful inflammation caused by decompression sickness (the bends) in divers. Thirty-six healthy, trained divers will be exposed to high pressure in a hyperbaric chamber, then given either the drug or a placebo before or after the exposure. Researchers will measure inflammatory markers in the blood and check for gas bubbles to see if the drug helps control the body's response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPRESSION SICKNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Maryland School of Medicine

    Baltimore, Maryland, 21201, United States

Conditions

Explore the condition pages connected to this study.